article · 2013
Budget Impact of the Introduction of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir, the First Integrase Inhibitor-Based Single Tablet Antiretroviral Regimen for HIV Treatment, to Third Party Payers in the United States
1 citationsDOI: https://doi.org/10.1016/j.jval.2013.08.128